International Statistic of the Year: Race for a COVID-19 vaccine

The coronavirus vaccine was developed faster than any vaccine in history. It took just 332 days from the first sequencing of the virus genome to the first vaccines given to the public.

Liberty Vittert, Professor of the Practice of Data Science, Washington University in St Louis • conversation
Dec. 18, 2020 ~5 min

genome covid-19 coronavirus statistics fda vaccines sars-cov-2 cdc vaccine-development government-funding operation-warp-speed

FDA authorized first over-the-counter COVID-19 test – useful but not a game changer

A new over-the-counter COVID-19 test has been authorized by the FDA. Though it can be used to test people with and without symptoms, moderate cost and limited production mean it isn't a game-changer.

Zoë McLaren, Associate Professor of Public Policy, University of Maryland, Baltimore County • conversation
Dec. 17, 2020 ~5 min

covid-19 coronavirus fda testing cdc centers-for-disease-control emergency-use-authorization antigen-test covid-test rapid-test over-the-counter

Why paying people to get the coronavirus vaccine won't work

Millions of Americans say they won't get the vaccine. Will money change their minds? And is luring them with cash the right approach?

Robert Gatter, Professor of Law, Saint Louis University • conversation
Dec. 11, 2020 ~10 min

 covid-19  coronavirus  fda  vaccination  covid-19-vaccine  pfizer  moderna  emergency-use-authorization  eua

What are emergency use authorizations, and do they guarantee that a vaccine or drug is safe?

The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?

Jeremy Greene, Professor of Medicine, Johns Hopkins University • conversation
Dec. 3, 2020 ~10 min

covid-19 coronavirus fda vaccines coronavirus-vaccine pfizer aids moderna emergency-use-authorization astrazeneca covid-19-vaccines eua fda-drug-approval-process

CBD sales are soaring, but evidence is still slim that the cannabis derivative makes a difference for anxiety or pain

The jury's still out on whether or not CBD relieves stress and anxiety.

Hilary A. Marusak, Assistant Professor, Wayne State University • conversation
Nov. 17, 2020 ~10 min

anxiety stress fda cannabinoids cannabis marijuana epilepsy cbd opioids

CBD sales soaring, but evidence still slim that the cannabis derivative makes a difference for anxiety or pain

The jury's still out on whether or not CBD relieves stress and anxiety.

Hilary A. Marusak, Assistant Professor, Wayne State University • conversation
Nov. 17, 2020 ~10 min

anxiety stress fda cannabinoids cannabis marijuana epilepsy cbd opioids

Ingredients in flu vaccine won't hurt you – two pharmacists explain why

Many people object to the added ingredients in vaccines. But pharmacists explain why those fears are unwarranted.

Anne P. Kim, Clinical assistant professor, Washington State University • conversation
Nov. 13, 2020 ~9 min

influenza autism fda flu anti-vaccination viruses immune-response anti-vaxxers flu-vaccine

How and when will we know that a COVID-19 vaccine is safe and effective?

Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?

William Petri, Professor of Medicine, University of Virginia • conversation
Sept. 22, 2020 ~10 min

covid-19 immune-system pandemic fda vaccines sars-cov-2 phase-3-trial immune-response vaccine-trials covid-19-vaccine vaccine-safety vaccine-approval

Will the new 15-minute COVID-19 test solve US testing problems?

The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.

Zoë McLaren, Associate Professor of Public Policy, University of Maryland, Baltimore County • conversation
Sept. 1, 2020 ~6 min

covid-19 coronavirus fda screening sars-cov-2 food-and-drug-administration testing viruses abbott emergency-use-authorization antigen-test pcr-testing covid-test

FDA is departing from long-standing procedures to deal with public health crises, and this may foreshadow problems for COVID-19 vaccines

The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?

Yaniv Heled, Associate Professor of Law, Georgia State University • conversation
Aug. 27, 2020 ~10 min

covid-19 fda coronavirus-2020 covid-19-vaccine convalescent-plasma

/

3